flecainide has been researched along with Sarcoma, Ewing in 1 studies
Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).
Sarcoma, Ewing: A malignant tumor of the bone which always arises in the medullary tissue, occurring more often in cylindrical bones. The tumor occurs usually before the age of 20, about twice as frequently in males as in females.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avent, Y | 1 |
| Johnson, S | 1 |
| Henderson, N | 1 |
| Wilder, K | 1 |
| Cresswell, J | 1 |
| Elbahlawan, L | 1 |
1 other study available for flecainide and Sarcoma, Ewing
| Article | Year |
|---|---|
Successful use of a rapid response team in the pediatric oncology outpatient setting.
Topics: Adolescent; Anti-Arrhythmia Agents; Antineoplastic Agents; Bone Neoplasms; Flecainide; Hospital Rapi | 2010 |